Pain Management Drugs Market, By Drugs Type (Anticonvulsants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids (Oxycodones, Hydrocodones, Tramadol, and Others), Antidepressants, and Others), By Application (Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-operative Pain, Cancer Pain, and Others), By Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospitals Pharmacies), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI10918 | Publish Date: March 2024 | No. of Pages: 179

Global Pain Management Drugs Market Overview

Pain management drugs are widely used in the management of pain for different chronic conditions such as cancer, and neuropathic pain etc. Today there is variety of drugs such as Non-steroidal Anti-inflammatory Drugs (NSAIDS), and Opioids etc. 

Geriatric population is more exposed to different types of pain. Hence, the increasing rates of geriatric population is also expected to upsurge the demand for pain management drugs in upcoming period of time.  For instance, as per Population Reference Bureau the number of number of Americans ages 65 and older is projected to more than double from 46 million today to over 98 million by 2060.

Furthermore, the launches of new drugs in market by key players are also expected to drive the market growth over forecast period. For instance, February 2018, KemPharm, Inc. received U.S. Food and Drug Administration (FDA) approval for its New Drug Application (NDA) for Apadazindicated for the short-term (no more than 14 days) management of acute pain severe.

The pain management drugs market has been segmented on the basis of product type, application, distribution channel, and region.

The drugs type segment includes Selective Estrogen Receptor Modulator, Anticonvulsants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids (Oxycodones, Hydrocodones, Tramadol, and Others.

On the basis of application, the pain management drugs market has been segmented into neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, cancer pain, and others.

On the basis of distribution channel, the pain management drugs market has been segmented in retail pharmacies, online pharmacies and hospitals pharmacies.

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the pain management drugs market includes, Bayer AG, DURECT Corporation, Pfizer Inc., BTG International Ltd, Novartis AG, A.P. Pharma, Inc., among others.

Global Pain Management Drugs Market Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Preview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drugs Type
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
      • Drivers- Restraints Impact Analysis
      • PEST Analysis
      • Porter’s Five Forces Analysis
  4. Market Segmentation, By Drugs Type, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Selective Estrogen Receptor Modulator
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Anticonvulsants
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Anesthetics
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Opioids
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

Ø  Oxycodones

§  Introduction

§  Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

Ø  Hydrocodones

§  Introduction

§  Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

Ø  Tramadol

§  Introduction

§  Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

Ø  Others

§  Introduction

§  Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

  • Others
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  1. Market Segmentation, Application, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Neuropathic Pain
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Fibromyalgia
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Chronic Back Pain
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Arthritic Pain
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Migraine
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Post-operative Pain
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Cancer Pain
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Others
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  2. Market Segmentation, By Distribution Channel, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Hospitals
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  3. Global Market, By Region, 2018 – 2028, (US$ Mn)
    • Introduction
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn),  By Drugs Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  U.S.

Ø  Canada

  • Latin America
    • Market Size and Forecast (US$ Mn),  By Drugs Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Brazil

Ø  Mexico

Ø  Argentina and Chile

Ø  Rest of Latin America

  • Europe
    • Market Size and Forecast (US$ Mn),  By Drugs Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Germany

Ø  UK

Ø  France

Ø  Russia

Ø  Italy

Ø  Switzerland

Ø  Sweden

Ø  Rest of Europe

  • Asia Pacific
    • Market Size and Forecast (US$ Mn),  By Drugs Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  China

Ø  India

Ø  Australia & New Zealand

Ø  Japan

Ø  South Korea

Ø  Rest of Asia Pacific

  • Middle East
    • Market Size and Forecast (US$ Mn),  By Drugs Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  GCC

Ø  Israel

Ø  Saudi Arabia

Ø  UAE

Ø  Rest of Middle East

  • Africa
    • Market Size and Forecast (US$ Mn),  By Drugs Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  North Africa

Ø  Central Africa

Ø  South Africa

  1. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Bayer AG

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Pfizer Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • DURECT Corporation

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • BTG International Ltd

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Novartis AG

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • A.P. Pharma, Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  •  KemPharm, Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Analyst Views
  1. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The pain management drugs market has been segmented on the basis of product type, application, distribution channel, and region.

Geriatric population is more exposed to different types of pain. Hence, the increasing rates of geriatric population is also expected to upsurge the demand for pain management drugs in upcoming period of time.

High cost of drugs might hampers the market

Key players operating in the pain management drugs market includes, Bayer AG, DURECT Corporation, Pfizer Inc., BTG International Ltd, Novartis AG, A.P. Pharma, Inc., among others.

North America is expected to account major market share as compared to that of other regions.